Literature DB >> 32594806

Association Between the European Society of Cardiology/European Society of Hypertension Heart Rate Thresholds for Cardiovascular Risk and Neuroadrenergic Markers.

Guido Grassi1, Fosca Quarti-Trevano1, Gino Seravalle1, Raffaella Dell'Oro1, Rita Facchetti1, Giuseppe Mancia2.   

Abstract

The recent European Society of Cardiology/European Society of Hypertension hypertension guidelines identify resting heart rate (HR) values >80 bpm as predictors of cardiovascular risk, with the unproven assumption that this might reflect the presence of a sympathetic overdrive. In the present study, we tested this hypothesis throughout the use of direct and indirect sympathetic markers. In 193 untreated moderate essential hypertensives aged 50.4±0.6 years (mean±SEM), we measured clinic and ambulatory blood pressure and corresponding HR, venous plasma norepinephrine (high performance liquid chromatography), and muscle sympathetic nerve traffic (microneurography). We then subdivided the study population into 2 groups according to HR < or >80 bpm. Eighty-four patients displayed resting HR >80 bpm, which was this cutoff value in the remaining 109 patients, the 2 groups showing superimposable age, and sex distribution. Clinic and ambulatory blood pressure were similar in the 2 groups, whereas left ventricular mass index was significantly greater in the group with HR >80 bpm. Muscle sympathetic nerve traffic values were also significantly greater in this latter group (72.77±0.9 versus vs 36.83±1.3 bursts/min, P<0.0001); this being the case also for norepinephrine (293.0±8.7 versus 254.1±8.9 pg/mL, P<0.002). In the whole population, there was a significant direct relationship between muscle sympathetic nerve traffic, norepinephrine, left ventricular mass index, and HR values. Similar results were obtained when 24-hour HR values were analyzed. Thus patients with hypertension displaying HR >80 bpm are characterized by a marked sympathetic overdrive, particularly when direct adrenergic markers are used. This finding suggests that cardiac and peripheral sympathetic activation are involved in the increased cardiovascular risk detected in this group of patients.

Entities:  

Keywords:  blood pressure; heart rate; hypertension; norepinephrine; risk

Year:  2020        PMID: 32594806     DOI: 10.1161/HYPERTENSIONAHA.120.14804

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  5 in total

1.  Isolated nocturnal hypertension in relation to host and environmental factors and clock genes.

Authors:  Jian-Feng Huang; Dong-Yan Zhang; Chang-Sheng Sheng; De-Wei An; Mingxuan Li; Yi-Bang Cheng; Qian-Hui Guo; Ying Wang; Ji-Guang Wang; Yan Li
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-08-09       Impact factor: 2.885

2.  Association Between Heart Rate and Major Adverse Cardiovascular Events Among 9,991 Hypertentive Patients: A Multicenter Retrospective Follow-Up Study.

Authors:  Ningling Sun; Yuanyuan Chen; Yang Xi; Hongyi Wang; Luyan Wang
Journal:  Front Cardiovasc Med       Date:  2021-12-03

3.  Heart rate thresholds for cardiovascular risk and sympathetic activation in the metabolic syndrome.

Authors:  Gino Seravalle; Jennifer Vanoli; Concetta Molisano; Valeria Merati; Guido Grassi
Journal:  Acta Diabetol       Date:  2022-07-29       Impact factor: 4.087

4.  Association of Urine Metanephrine Levels with CardiometaBolic Risk: An Observational Retrospective Study.

Authors:  Mirko Parasiliti-Caprino; Chiara Obert; Chiara Lopez; Martina Bollati; Fabio Bioletto; Chiara Bima; Filippo Egalini; Alessandro Maria Berton; Nunzia Prencipe; Fabio Settanni; Valentina Gasco; Giulio Mengozzi; Ezio Ghigo; Mauro Maccario
Journal:  J Clin Med       Date:  2021-05-04       Impact factor: 4.241

5.  The Sympathetic Nervous System in Hypertension: Roadmap Update of a Long Journey.

Authors:  Guido Grassi
Journal:  Am J Hypertens       Date:  2021-12-01       Impact factor: 2.689

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.